Company
United StatesPublic company, NASDAQ: NVAXNovavax Inc. (NASDAQ: NVAX), Germantown, MD – FDA Inspections
Inspection records and compliance data for Novavax Inc. in Germantown, MD. Access full analysis and detailed observations. Publicly traded as NASDAQ: NVAX.
Company Profile
This profile covers Novavax Inc. based in Germantown, MD, United States.
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 1 inspection · last June 18, 2024
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Charles River Laboratories France - CRLF
ViruSure Forschung und Entwicklung GmbH
Micromun Privates Institut für Mikrobiologische Forschung GmbH
BioReliance Corporation
Boston Analytical Inc.
Spectral Data Services, Inc.
Nelson Laboratories, LLC
Eurofins BioPharma Product Testing Columbia, Inc.
ZebraSci Inc.
Microworks, Inc.
Company Information
Name
Novavax Inc.
Stock ticker
NVAX
Exchange
NASDAQ
Share price
$8.76
Market cap
$1.4B
Price as of
November 13, 2026
Address
20425 Seneca Meadows Parkway, Germantown, MD 20876, United States
Country
United States
ID: d1492e33-b0e7-49f6-835f-d73adaa12e7b